This week CDC discusses vaccine recommendations; a provider offers insights on administering live biotherapeutics; and early administration of simnotrelvir plus ritonavir shortened the time to sustained resolution of COVID-19 symptoms.
High Rates of HCV Reinfection in NYC
World Hepatitis Day: Where Do We Go From Here?
WHO Prequalifies First Self-Test for Hepatitis C Virus
Vaccine Equality vs Equity with Dr. Jacinda Abdul-Mutakabbir
Patients Less Likely to Receive Linkage to Hepatitis C Care in Emergency Department
Unraveling Hepatitis E Virus Adaptation